As in cutaneous and acral melanoma, the mutational profile categorizes MM into different molecular groups: BRAF-mutated; RAS-mutated; NF1-loss; and triple wild-type (absence of mutations in BRAF, RAS and NF1; but the presence of KIT mutations and/or amplifications) [28]. This evidence concerns the gene BRAF and Miyoshi myopathy.